Inovio Awarded up to $56 Million from CEPI to Advance DNA Vaccines Against Lassa Fever and MERS Read more
Zealand and Roche Diabetes Care enter Phase 3 study collaboration for Treatment of CHI with Dasiglucagon Read more
Novartis drug Afinitor DISPERZ receives FDA approval to treat TSC-associated partial-onset seizures Read more
Protalex Initiates Fourth Cohort Dosing of Phase 1/2 Study of PRTX-100 in Immune Thrombocytopenia Read more
Allele Receives Tissue Bank License for Manufacturing and Distribution of cGMP-compliant iPSCs Read more